PL2658537T3 - Sposób leczenia skóry modulatorami mikroRNA - Google Patents
Sposób leczenia skóry modulatorami mikroRNAInfo
- Publication number
- PL2658537T3 PL2658537T3 PL11853582T PL11853582T PL2658537T3 PL 2658537 T3 PL2658537 T3 PL 2658537T3 PL 11853582 T PL11853582 T PL 11853582T PL 11853582 T PL11853582 T PL 11853582T PL 2658537 T3 PL2658537 T3 PL 2658537T3
- Authority
- PL
- Poland
- Prior art keywords
- treating skin
- microrna modulators
- microrna
- modulators
- skin
- Prior art date
Links
- 108700011259 MicroRNAs Proteins 0.000 title 1
- 239000002679 microRNA Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
- C07C311/16—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom
- C07C311/17—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom to an acyclic carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/255—Esters, e.g. nitroglycerine, selenocyanates of sulfoxy acids or sulfur analogues thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
- A61K8/466—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur containing sulfonic acid derivatives; Salts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
- A61K8/4926—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/18—Antioxidants, e.g. antiradicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/74—Biological properties of particular ingredients
- A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
- A61K2800/782—Enzyme inhibitors; Enzyme antagonists
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/136—Screening for pharmacological compounds
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/148—Screening for cosmetic compounds
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/178—Oligonucleotides characterized by their use miRNA, siRNA or ncRNA
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Birds (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Biotechnology (AREA)
- Pathology (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Biophysics (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US12/979,695 US8455518B2 (en) | 2010-12-28 | 2010-12-28 | Method of treating skin with microRNA modulators |
| PCT/US2011/061656 WO2012091824A1 (en) | 2010-12-28 | 2011-11-21 | METHOD OF TREATING SKIN WITH microRNA MODULATORS |
| EP20110853582 EP2658537B1 (en) | 2010-12-28 | 2011-11-21 | METHOD OF TREATING SKIN WITH microRNA MODULATORS |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2658537T3 true PL2658537T3 (pl) | 2015-08-31 |
Family
ID=46317882
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL11853582T PL2658537T3 (pl) | 2010-12-28 | 2011-11-21 | Sposób leczenia skóry modulatorami mikroRNA |
| PL15156211.3T PL2987534T3 (pl) | 2010-12-28 | 2011-11-21 | Sposób leczenia skóry modulatorami mikroRNA |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL15156211.3T PL2987534T3 (pl) | 2010-12-28 | 2011-11-21 | Sposób leczenia skóry modulatorami mikroRNA |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US8455518B2 (pl) |
| EP (2) | EP2658537B1 (pl) |
| JP (1) | JP5918783B2 (pl) |
| CN (2) | CN103249409B (pl) |
| AR (1) | AR084598A1 (pl) |
| BR (1) | BR112013014597B1 (pl) |
| CA (2) | CA3010395C (pl) |
| HU (1) | HUE068372T2 (pl) |
| MX (2) | MX345299B (pl) |
| PL (2) | PL2658537T3 (pl) |
| TW (1) | TWI605833B (pl) |
| WO (1) | WO2012091824A1 (pl) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL2588593T3 (pl) | 2010-06-30 | 2018-01-31 | Avon Prod Inc | Kompozycje i sposoby stymulowania MAGP-1 dla poprawy wyglądu skóry |
| US8815265B2 (en) * | 2010-06-30 | 2014-08-26 | Avon Products, Inc. | Cosmetic use of N-substituted sulfonyloxybenzylamines and related compounds |
| US8632827B2 (en) | 2011-12-13 | 2014-01-21 | Avon Products, Inc | Modulation of thymosin beta-4 in skin |
| JP6120398B2 (ja) * | 2012-11-02 | 2017-04-26 | 国立大学法人三重大学 | 水溶性フィブリリン組成物による弾性線維増強法 |
| WO2014093053A1 (en) * | 2012-12-11 | 2014-06-19 | Avon Products, Inc. | Modulation of thymosin beta-4 in skin |
| WO2014092686A1 (en) * | 2012-12-11 | 2014-06-19 | Avon Products, Inc. | Stephanotis jasminoides extracts and methods of use |
| US9186316B2 (en) | 2012-12-11 | 2015-11-17 | Avon Products, Inc. | Stephanotis jasminoides extracts and methods of use |
| TW201422246A (zh) | 2012-12-11 | 2014-06-16 | Avon Prod Inc | 藉由調節wipi-1改善皮膚老化外觀之方法 |
| US9445981B2 (en) * | 2012-12-20 | 2016-09-20 | Avon Products, Inc | PLOD-2 stimulators and their use in the treatment of skin |
| CN110205366B (zh) * | 2018-02-28 | 2022-06-21 | 伽蓝(集团)股份有限公司 | 一种皮肤内源性老化靶标的筛选方法及改善皮肤内源性老化的活性物及其筛选方法 |
| CN111041082B (zh) * | 2018-10-11 | 2023-11-07 | 伽蓝(集团)股份有限公司 | 一种以皮肤光老化靶标筛选改善皮肤光老化的活性物的方法及改善皮肤光老化的活性物 |
| CN111249466B (zh) * | 2020-03-14 | 2022-04-15 | 浙江大学医学院附属第一医院 | 丹参酮ⅡA与miR-29b抑制剂联合在制备治疗肌腱粘连的药物中的应用 |
| WO2023012722A1 (en) * | 2021-08-06 | 2023-02-09 | Leadermed Champion Limited | miRNA-BASED COMPOSITIONS AND METHODS OF USE THEREOF |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9918023D0 (en) * | 1999-07-30 | 1999-09-29 | Unilever Plc | Skin care composition |
| JP4371812B2 (ja) | 2001-09-28 | 2009-11-25 | マックス−プランク−ゲゼルシャフト・ツア・フェルデルング・デア・ヴィッセンシャフテン・エー・ファオ | マイクロrna分子 |
| UA82835C2 (en) * | 2001-12-03 | 2008-05-26 | Reddys Lab Ltd Dr | ?-aryl-?-oxysubstituted propionuc acid derivatives and pharmaceutical composition based thereon |
| EP2295604B1 (en) | 2004-02-09 | 2015-04-08 | Thomas Jefferson University | Diagnosis and treatment of cancers with microRNA located in or near cancer-associated chromosomal features |
| WO2006133588A1 (en) * | 2005-06-13 | 2006-12-21 | Oncalis Ag | ARYL UREA COMPOUNDS AS β-SECRETASE INHIBITORS |
| JP5192380B2 (ja) * | 2005-09-08 | 2013-05-08 | 株式會社アモーレパシフィック | 皮膚老化防止用皮膚外用剤組成物 |
| NZ583025A (en) * | 2007-07-31 | 2012-06-29 | Univ Texas | Micro-rnas that control myosin expression and myofiber identity |
| NZ583024A (en) * | 2007-07-31 | 2012-04-27 | Regents The Univeristy Of Texas System Board Of | An agonist of miR-29a, miR-29b or miR-29c that prevents tissue fibrosis and uses thereof |
| EP2491007B1 (en) | 2009-10-23 | 2013-09-25 | Boehringer Ingelheim International GmbH | Inhibitors of the microsomal prostaglandin E2 synthase-1 |
| PL2588593T3 (pl) * | 2010-06-30 | 2018-01-31 | Avon Prod Inc | Kompozycje i sposoby stymulowania MAGP-1 dla poprawy wyglądu skóry |
| US8815265B2 (en) * | 2010-06-30 | 2014-08-26 | Avon Products, Inc. | Cosmetic use of N-substituted sulfonyloxybenzylamines and related compounds |
| US20120171133A1 (en) * | 2010-12-30 | 2012-07-05 | Avon Products, Inc. | Modulation of Dynein in Skin |
-
2010
- 2010-12-28 US US12/979,695 patent/US8455518B2/en active Active
-
2011
- 2011-11-21 PL PL11853582T patent/PL2658537T3/pl unknown
- 2011-11-21 PL PL15156211.3T patent/PL2987534T3/pl unknown
- 2011-11-21 BR BR112013014597-8A patent/BR112013014597B1/pt not_active IP Right Cessation
- 2011-11-21 HU HUE15156211A patent/HUE068372T2/hu unknown
- 2011-11-21 CA CA3010395A patent/CA3010395C/en active Active
- 2011-11-21 WO PCT/US2011/061656 patent/WO2012091824A1/en not_active Ceased
- 2011-11-21 CN CN201180058494.3A patent/CN103249409B/zh not_active Expired - Fee Related
- 2011-11-21 MX MX2013006059A patent/MX345299B/es active IP Right Grant
- 2011-11-21 EP EP20110853582 patent/EP2658537B1/en not_active Not-in-force
- 2011-11-21 MX MX2017000916A patent/MX367271B/es unknown
- 2011-11-21 CA CA2817395A patent/CA2817395C/en active Active
- 2011-11-21 CN CN201410832216.4A patent/CN104622704B/zh not_active Expired - Fee Related
- 2011-11-21 JP JP2013547479A patent/JP5918783B2/ja not_active Expired - Fee Related
- 2011-11-21 EP EP15156211.3A patent/EP2987534B1/en active Active
- 2011-12-07 TW TW100145140A patent/TWI605833B/zh not_active IP Right Cessation
- 2011-12-27 AR ARP110104940A patent/AR084598A1/es unknown
-
2013
- 2013-05-30 US US13/905,708 patent/US8865740B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| MX367271B (es) | 2019-08-12 |
| JP2014509307A (ja) | 2014-04-17 |
| EP2987534B1 (en) | 2024-07-10 |
| US8865740B2 (en) | 2014-10-21 |
| HUE068372T2 (hu) | 2024-12-28 |
| US20120165373A1 (en) | 2012-06-28 |
| PL2987534T3 (pl) | 2024-11-12 |
| TWI605833B (zh) | 2017-11-21 |
| US20130253053A1 (en) | 2013-09-26 |
| US8455518B2 (en) | 2013-06-04 |
| CN103249409B (zh) | 2016-07-06 |
| EP2658537B1 (en) | 2015-04-29 |
| CA3010395A1 (en) | 2012-07-05 |
| HK1187251A1 (zh) | 2014-04-04 |
| EP2658537A4 (en) | 2014-06-25 |
| CN104622704A (zh) | 2015-05-20 |
| HK1206591A1 (en) | 2016-01-15 |
| CN104622704B (zh) | 2017-12-22 |
| EP2987534A1 (en) | 2016-02-24 |
| WO2012091824A1 (en) | 2012-07-05 |
| MX2013006059A (es) | 2013-07-03 |
| CA3010395C (en) | 2020-12-15 |
| CA2817395C (en) | 2019-03-05 |
| TW201231078A (en) | 2012-08-01 |
| BR112013014597B1 (pt) | 2020-06-30 |
| EP2658537A1 (en) | 2013-11-06 |
| BR112013014597A2 (pt) | 2016-09-20 |
| CN103249409A (zh) | 2013-08-14 |
| AR084598A1 (es) | 2013-05-29 |
| JP5918783B2 (ja) | 2016-05-18 |
| MX345299B (es) | 2017-01-24 |
| CA2817395A1 (en) | 2012-07-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUE068372T2 (hu) | Eljárás bõr kezelésére mikroRNS-modulátorokkal | |
| GB201110095D0 (en) | Method of treatment | |
| EP2773754A4 (en) | Methods of Treatment | |
| ZA201503332B (en) | Water treatment composition and method of using same | |
| GB201018147D0 (en) | Method of treatment | |
| ZA201408353B (en) | Method of treating hair | |
| EP2643001A4 (en) | METHOD OF TREATING CANCER | |
| ZA201408342B (en) | Method of treating hair | |
| IL230433A0 (en) | Pain management methods | |
| PH12013501056A1 (en) | Anaerobic treatment method | |
| ZA201303222B (en) | Composition and method for treating skin conditions | |
| ZA201408343B (en) | Method of treating hair | |
| IL256026B (en) | Treatment methods | |
| GB201003920D0 (en) | Method of treatment | |
| GB201013975D0 (en) | Method of treating desease | |
| ZA201108493B (en) | Method of treating hair | |
| GB201018149D0 (en) | Method of treatment | |
| PL3821897T3 (pl) | Środek i sposób leczenia naczyń krwionośnych | |
| GB201020045D0 (en) | Method for the treatment of biogas | |
| EP2585103A4 (en) | METHOD OF TREATMENT | |
| GB201020015D0 (en) | Method of treatment | |
| EP2791324A4 (en) | PROCESSING METHOD | |
| GB201005071D0 (en) | Method of treatment | |
| GB201003917D0 (en) | Method of treatment | |
| GB201000318D0 (en) | Method of treatment |